Last $2.91 USD
Change Today -0.08 / -2.68%
Volume 4.2M
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 04/15/14 All times are local (Market data is delayed by at least 15 minutes).

antares pharma inc (ATRS) Snapshot

Open
$2.98
Previous Close
$2.99
Day High
$3.06
Day Low
$2.70
52 Week High
10/14/13 - $5.15
52 Week Low
04/15/14 - $2.70
Market Cap
378.1M
Average Volume 10 Days
2.5M
EPS TTM
$-0.16
Shares Outstanding
129.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ANTARES PHARMA INC (ATRS)

Related News

No related news articles were found.

antares pharma inc (ATRS) Related Businessweek News

View More BusinessWeek News

antares pharma inc (ATRS) Details

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP, a pre-filled methotrexate syringe with Medi-Jet technology to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; and Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle. Its transdermal products comprise Gelnique3%, an oxybutynin gel product for the treatment of overactive bladder; and Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. The company is also developing OTREXUP for the treatment poly-articular-course juvenile RA and psoriasis; Vibex QS T for testosterone replacement therapy for men suffering from symptomatic testosterone deficiency; Vibex auto injectors; and disposable pen injectors. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; Meda Pharmaceuticals; Pfizer Inc; Population Council; and LEO Pharma. The company was founded in 1979 and is headquartered in Ewing, New Jersey.

60 Employees
Last Reported Date: 03/13/14
Founded in 1979

antares pharma inc (ATRS) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $477.0K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $337.5K
Compensation as of Fiscal Year 2012.

antares pharma inc (ATRS) Key Developments

Antares Pharma Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2013

Antares Pharma Inc. reported consolidated earnings results for the fourth quarter and year ended December 31, 2013. For the quarter, total revenue was $4.745 million against $5.501 million a year ago. Operating loss was $5.947 million against $5.044 million a year ago. Net loss before income taxes was $5.935 million against $5.011 million a year ago. Net loss was $5.635 million or $0.04 per basic and diluted share against $5.011 million or $0.04 per basic and diluted share a year ago. For the year, total revenue was $20.618 million against $22.575 million a year ago. Operating loss was $20.850 million against $11.451 million a year ago. Net loss before income taxes was $20.807 million against $11.427 million a year ago. Net loss was $20.507 million or $0.16 per basic and diluted share against $11.427 million or $0.10 per basic and diluted share a year ago.

Antares Pharma Inc., Q4 2013 Earnings Call, Mar 13, 2014

Antares Pharma Inc., Q4 2013 Earnings Call, Mar 13, 2014

Antares Pharma Inc. to Report Q4, 2013 Results on Mar 13, 2014

Antares Pharma Inc. announced that they will report Q4, 2013 results at 9:00 AM, Eastern Standard Time on Mar 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.91 USD -0.08

ATRS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Auxilium Pharmaceuticals Inc $24.79 USD +0.16
Bioject Medical Technologies Inc $0.13 USD -0.047
InspireMD Inc $2.39 USD -0.108
West Pharmaceutical Services Inc $43.03 USD -0.02
Ypsomed Holding AG SFr.78.00 CHF +0.10
View Industry Companies
 

Industry Analysis

ATRS

Industry Average

Valuation ATRS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 18.5x
Price/Book 5.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit www.antarespharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.